This third webinar in our series will focus on how conducting clinical trials in Russia can help cut the cost of clinical research.
The High Price of Clinical Research: Who’s Guilty and What To Do?
A patriarch of randomized clinical trials in Russia, Dr. Sergei Varshavsky, in his signature provocative manner, will discuss the problem of the high price that governments and societies pay for development of new cures. He will provide insight into the roles played by different interest groups in raising the price of clinical trials over the past two decades. He will analyze the nature, causes and consequences of the major components of that cost, as well as propose an optimistic vision for a way out.
Clinical Trials in Russia: The Recent, Past and Near Future
Mr. Stefanov, a proponent of openness and transparency in the CRO business, will analyze the current state of the clinical trials market in Russia and review the upcoming trends as well as historical data. His report will follow SynRG’s Orange Paper and discuss the new regulatory initiatives that may affect the players and influence the future landscape. Figures and tables will provide valuable data for risk-benefit analysis and decision-making.
A live Q&A with the audience will follow the main presentation.
Sergei Varshavsky, MD, PhD, Sr. VP, Global Strategy, Synergy Research Group
A pioneer of randomized clinical trials in Russia and Eastern Europe, Dr. Varshavsky founded Evidence CPR – one of the first and most successful CROs in the region – as early as 1989, and has remained its CEO until Evidence’s acquisition in 2008 by Worldwide Clinical Trials, a global CRO, where he served as Sr. VP until 2011. At the time of acquisition Evidence CPR operated 7 offices in 4 countries with over 400 employees. He has been living and working in San Francisco since 1999.
Sergei Varshavsky received his medical degree at Pavlov Medical University in 1983 and PhD degree at Medical Academy of Postgraduate Education in 1993, both in St. Petersburg, Russia. Besides corporate governance, his expertise lies in the fields of conducting mega-trials, vendor and site selection, building alliances, project controls, and managing the cost of clinical research.
Igor Stefanov, Director, General Manager, Synergy Research Group
As General Manager, Mr. Stefanov is responsible for providing leadership that positions the company at the forefront of the clinical trial industry in Russia. With more than 15 years of experience in business consulting and general management, Mr. Stefanov has focused his energies on developing strategic plan to advance the company’s mission and objectives and to promote revenue, profitability and growth of Synergy Research Group as an organization. Mr. Stefanov oversees company operations to ensure production efficiency, quality, service, and cost-effective management of resources.
Prior to joining Synergy Research Group in January 2007, Mr. Stefanov was General Manager of Smartlock, the Russian biometric company and was recognized as Entrepreneur of the Month by the Russian edition of Forbes magazine in May 2005. With an MBA in Economics and a strong local expertise Mr. Stefanov has been providing business consulting services to large multi-national companies including Pfizer, J&J, GlaxoSmithKline, F.Hoffmann-La Roche and others in Russia since 1993.
Who Should Attend?
- Pharmaceutical and biotechnology companies (clinical research, budgeting, outsourcing and project managers)
- Contract research organizations (local and global)
- Government agencies controlling the health care and medical research costs
- Media and journalists writing on pharmaceutical market, health care and clinical research issues
- Clinical research vendors (investigators, CRAs, project managers, regulatory specialists, etc.)
- Clinical research professional associations and patient advocacy groups
Synergy Research Group (SynRG™) is a leading Russian Contract Research Organization (CRO) successfully assisting Pharmaceutical and biotechnology companies, as well as global CROs in conducting clinical trials in Russia and the Commonwealth of Independent States (CIS) since 2002.
SynRG was established as an answer to the growing demand for clinical trials in Eastern Europe. We are committed to provide high quality services capitalizing on our in-depth knowledge of international and local regulations, long-term relationships with central and peripheral medical institutions, and a broad network of investigators with vast clinical research experience in various therapeutic areas.
SynRG is a client-oriented company with emphasis on true partnership relations with the client. Our collaborative effort is based on a mutual respect for one another’s expertise, knowledge, and skills; through close cooperation we eliminate territorial issues, communicate efficiently and work proactively among team members to ensure success of the project. With SynRG you will feel like our only client!